⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6300746 | 0.85 | KDM4E (0.31) | — | |
| SCHEMBL14441612 | 0.77 | KDM4E (0.31) | — | |
| SCHEMBL22939433 | 0.77 | LMNA (0.36) | — | |
| SCHEMBL649183 | 0.68 | — | — | |
| SCHEMBL3670357 | 0.67 | — | — | |
| SCHEMBL29948439 | 0.64 | — | — | |
| SCHEMBL9513293 | 0.63 | — | — | |
| SCHEMBL11213847 | 0.62 | — | — | |
| SCHEMBL5953737 | 0.62 | IDUA (0.42) | — | |
| SCHEMBL4165018 | 0.62 | LMNA (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4355740-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | Global Biolife Inc. (US) | 2024-04-24 | — | — | EP | disclosed |
| WO-2023212487-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | GLOBAL BIOLIFE INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| US-20220401403-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | GLOBAL BIOLIFE INC. | 2022-12-22 | — | — | US | disclosed |
| WO-2022265925-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | GLOBAL BIOLIFE INC. (US) | 2022-12-22 | — | — | WO | disclosed |
| US-20220249530-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | GLOBAL BIOLIFE INC. | 2022-08-11 | — | — | US | disclosed |
| US-11311563-B2 | Method and composition for preventing and treating viral infections | GLOBAL BIOLIFE INC. (US) | 2022-04-26 | — | — | US | disclosed |
| US-20210299088-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | GLOBAL BIOLIFE INC. | 2021-09-30 | — | — | US | disclosed |
| US-11033528-B2 | Method and composition for preventing and treating viral infections | GLOBAL BIOLIFE INC. (US) | 2021-06-15 | — | — | US | disclosed |
| EP-2129371-B1 | COMPOSITION FOR TREATING DIABETES AND METABOLIC DISORDERS WITH QUERCETIN, MYRCETIN AND CHLOROGENIC ACID | ATM METABOLICS LLLP (US) | 2021-05-05 | — | — | EP | disclosed |
| US-20200306281-A1 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | GLOBAL BIOLIFE INC. | 2020-10-01 | — | — | US | disclosed |
| US-20140031420-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM Metabolics LLC (US) | 2014-01-30 | — | — | US | disclosed |
| US-20120252887-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS LLLP (US) | 2012-10-04 | — | — | US | disclosed |
| US-8198319-B2 | Composition and method for treating diabetes and metabolic disorders | ATM METABOLICS, LLC | 2012-06-12 | — | — | US | disclosed |
| US-8034838-B2 | Composition and method for the treatment of neurological disorders | GLOBAL BIOLIFE, INC. | 2011-10-11 | — | — | US | disclosed |
| US-20110118345-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS, LLC | 2011-05-19 | — | — | US | disclosed |
| US-7943164-B2 | Contains quercetin, myricetin and chlorogenic acid; weight loss and weight control; inhibiting glucose absorption in the gut, enhancing glucose absorption by muscle tissue, inhibiting carbohydrate transport, inhibiting glucose/fat storage and inhibiting the manufacture of glucose by the liver | ATM METABOLICS, LLC | 2011-05-17 | — | — | US | disclosed |
| EP-2129371-A1 | COMPOSITION FOR TREATING DIABETES AND METABOLIC DISORDERS WITH QUERCETIN, MYRCETIN AND CHLOROGENIC ACID | ATM Metabolics LLLP (US) | 2009-12-09 | — | — | EP | disclosed |
| US-20090298932-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | GLOBAL BIOLIFE, INC. | 2009-12-03 | — | — | US | disclosed |
| WO-2008115723-A1 | COMPOSITION FOR TREATING DIABETES AND METABOLIC DISORDERS WITH QUERCETIN, MYRCETIN AND CHLOROGENIC ACID | ATM METABOLICS LLLP (US) | 2008-09-25 | — | — | WO | disclosed |
| US-20080234364-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS, LLC | 2008-09-25 | — | — | US | disclosed |